Literature DB >> 19022816

Protection against rheumatoid arthritis by HLA: nature and nurture.

A L Feitsma1, A H M van der Helm-van Mil, T W J Huizinga, R R P de Vries, R E M Toes.   

Abstract

Rheumatoid arthritis (RA) is a complex genetic disorder in which the HLA region contributes most to the genetic risk. HLA-DRB1 molecules containing the amino acid sequence QKRAA/QRRAA/RRRAA (ie, HLA-DRB1*0101, *0102, *0401, *0404, *0405, *0408, *0410, *1001 and *1402) at position 70-74 in the third hypervariable region of the DRB1 chain are associated with susceptibility to RA. HLA-DRB1 molecules containing the amino acids "DERAA" (ie, HLA-DRB1*0103, *0402, *1102, *1103, *1301, *1302 and *1304) at the same position are associated with protection from RA. Interestingly, not only inherited but also non-inherited HLA-antigens from the mother can influence RA susceptibility. A protective effect of "DERAA"-containing HLA-DRB1 alleles as non-inherited maternal antigen (NIMA) has recently been described. The underlying mechanism of this protective effect is currently unknown, although a possible explanation is covered below. In this review, an overview of the current knowledge on protection against RA is given and the inherited and NIMA effect of "DERAA"-containing HLA-DRB1 alleles are compared.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19022816     DOI: 10.1136/ard.2008.098509

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  15 in total

1.  Increased frequency of complement C4B deficiency in rheumatoid arthritis.

Authors:  William F C Rigby; Yee Ling Wu; Moe Zan; Bi Zhou; Sanna Rosengren; Cheryl Carlson; Whitney Hilton; C Yung Yu
Journal:  Arthritis Rheum       Date:  2012-05

2.  HLA-DRB1 the notorious gene in the mosaic of autoimmunity.

Authors:  María-Teresa Arango; Carlo Perricone; Shaye Kivity; Enrica Cipriano; Fulvia Ceccarelli; Guido Valesini; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

Review 3.  Human Leukocyte Antigen-Disease Associations in Rheumatoid Arthritis.

Authors:  Vincent van Drongelen; Joseph Holoshitz
Journal:  Rheum Dis Clin North Am       Date:  2017-08       Impact factor: 2.670

4.  Immunoglobulin (Ig)G1 and IgG4 anti-cyclic citrullinated peptide (CCP) associate with shared epitope, whereas IgG2 anti-CCP associates with smoking in patients with recent-onset rheumatoid arthritis (the Swedish TIRA project).

Authors:  K Martinsson; A Johansson; A Kastbom; T Skogh
Journal:  Clin Exp Immunol       Date:  2017-01-10       Impact factor: 4.330

Review 5.  HLA class II molecules influence susceptibility versus protection in inflammatory diseases by determining the cytokine profile.

Authors:  Ashutosh K Mangalam; Veena Taneja; Chella S David
Journal:  J Immunol       Date:  2013-01-15       Impact factor: 5.422

6.  Gender-biased regulation of human IL-17-producing cells in vitro by peptides corresponding to distinct HLA-DRB1 allele-coded sequences.

Authors:  Luz P Blanco; Melissa Plegue; Wai-Ping Fung-Leung; Joseph Holoshitz
Journal:  J Immune Based Ther Vaccines Antimicrob       Date:  2013-07-01

Review 7.  [Autoimmunity. Physiological control mechanisms and pathways to autoimmune disease].

Authors:  D Kabelitz; S Schreiber
Journal:  Internist (Berl)       Date:  2009-03       Impact factor: 0.743

8.  Effect of human leukocyte antigen homozygosity on rubella vaccine-induced humoral and cell-mediated immune responses.

Authors:  Richard B Kennedy; Inna G Ovsyannikova; Robert A Vierkant; Robert M Jacobson; Gregory A Poland
Journal:  Hum Immunol       Date:  2009-11-05       Impact factor: 2.850

9.  Immunogenicity of a rheumatoid arthritis protective sequence when acquired through microchimerism.

Authors:  Sami B Kanaan; Oyku Sensoy; Zhen Yan; Vijayakrishna K Gadi; Michael L Richardson; J Lee Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-09       Impact factor: 11.205

10.  Association of KCNB1 to rheumatoid arthritis via interaction with HLA-DRB1.

Authors:  Xiangjun Xiao; Yufang Zhang; Kai Wang
Journal:  BMC Proc       Date:  2009-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.